Pulse Biosciences, Inc. provided revenue guidance for the fourth quarter 2021. Preliminary unaudited full year 2021 revenue is expected to be in the range of $1.3 million to $1.4 million, including preliminary unaudited fourth quarter 2021 revenue of approximately $750,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.03 USD | -1.39% |
|
-2.83% | -1.72% |
Jun. 07 | Shelley D. Spray Does Not Stand for Reelection from the Board of Pulse Biosciences, Inc | CI |
May. 20 | Pulse Biosciences Moves New Record Date for Rights Offering | MT |
1st Jan change | Capi. | |
---|---|---|
-1.72% | 664M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+2.32% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- PLSE Stock
- News Pulse Biosciences, Inc.
- Pulse Biosciences, Inc. Provides Revenue Guidance for the Fourth Quarter 2021